Compare KMDA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | EHAB |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.6M | 690.3M |
| IPO Year | 2013 | 2020 |
| Metric | KMDA | EHAB |
|---|---|---|
| Price | $8.92 | $13.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $13.00 | ★ $13.84 |
| AVG Volume (30 Days) | 66.6K | ★ 2.2M |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | ★ 97.11 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,060,000,000.00 |
| Revenue This Year | $14.79 | $6.23 |
| Revenue Next Year | $11.38 | $4.35 |
| P/E Ratio | $24.59 | ★ N/A |
| Revenue Growth | N/A | ★ 2.44 |
| 52 Week Low | $5.54 | $6.47 |
| 52 Week High | $9.35 | $13.64 |
| Indicator | KMDA | EHAB |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 82.27 |
| Support Level | $6.69 | $7.61 |
| Resistance Level | $9.35 | N/A |
| Average True Range (ATR) | 0.27 | 0.11 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 72.63 | 99.83 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.